Azelastine
Brand names: ASTEPRO DYMISTA (in combination)
Therapeutic Indications
Azelastine is indicated for:
Seasonal allergic conjunctivitis
Irrespective of gender only Children (1 year - 12 years old) , Adolescents (12 years - 18 years old) Adults (18 years old or older)
Treatment and prevention of the symptoms of seasonal allergic conjunctivitis in adults and children 4 years and older.
For this indication, the medical literature mentions below treatments (click for details):
Treatment 1: Conjunctival - One drop in each eye twice or four times daily
Seasonal allergic rhinitis
Irrespective of gender only Children (1 year - 12 years old) , Adolescents (12 years - 18 years old) Adults (18 years old or older)
Azelastine is indicated for the treatment of both seasonal allergic rhinitis (e.g. hay fever) and perennial allergic rhinitis.
For this indication, the medical literature mentions below treatments (click for details):
Treatment 1: Nasal - One application (0.14 ml) in each nostril twice daily
Non-seasonal (perennial) allergic conjunctivitis
Irrespective of gender only Adolescents (12 years - 18 years old) Adults (18 years old or older)
Treatment of the symptoms of non-seasonal (perennial) allergic conjunctivitis in adults and children 12 years and older.
For this indication, the medical literature mentions below treatments (click for details):
Treatment 1: Ophthalmic - One drop in each eye twice to four times daily
Contraindications
Active ingredient Azelastine is contraindicated in the following cases: